ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Ryu21c,CT-P59,Wuhan-Hu-1,Table 2,Virus isolate,IC50,6.76,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,hCoV-19/South Korea/KDCA5439/2021,Table 2,Virus isolate,IC50,1237,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,hCoV-19/South Korea/KDCA1792/2020,Table 2,Virus isolate,IC50,499.5,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,hCoV-19/South Korea/KDCA1793/2020,Table 2,Virus isolate,IC50,365.6,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,hCoV-19/South Korea/KDCA2950/2021,Table 2,Virus isolate,IC50,161.5,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,S:614G,Table 2,Pseudovirus (MLV),IC50,0.219,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,S:452R+478K+681R,Table 2,Pseudovirus (MLV),IC50,21.52,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,S:13I+152C+452R,Table 2,Pseudovirus (MLV),IC50,6.819,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,S:452R+484Q+681R,Table 2,Pseudovirus (MLV),IC50,11.08,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,S:452R,Table 2,Pseudovirus (MLV),IC50,13.22,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,S:478K,Table 2,Pseudovirus (MLV),IC50,0.213,1,1000000,0.1,ng/ml,2021-07-27
Ryu21c,CT-P59,S:681H,Table 2,Pseudovirus (MLV),IC50,0.378,1,1000000,0.1,ng/ml,2021-07-27
